Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Catena-Dell'Osso

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|March 14, 2008
The role of oxytocin in neuropsychiatric disordersD Marazziti, M Catena Dell'osso
Current Medicinal Chemistry|November 12, 2009
Second messenger modulation: a novel target of future antidepressants?D Marazziti, M Catena Dell'Osso, G Consoli, et al.
Current Medicinal Chemistry|August 18, 2010
Past, present and future drugs for the treatment of obsessive-compulsive disorderD Marazziti, G Consoli, S Baroni, et al.
European Review for Medical and Pharmacological Sciences|June 18, 2013
Adolescent depression: clinical features and therapeutic strategiesB Nardi, G Francesconi, M Catena-Dell'osso, et al.
Current Medicinal Chemistry|June 9, 2011
Serotonin receptors of type 6 (5-HT6): what can we expect from them?D Marazziti, S Baroni, M Catena Dell'Osso, et al.
European Review for Medical and Pharmacological Sciences|January 3, 2013
Latest advancements in the pharmacological treatment of binge eating disorderD Marazziti, M Corsi, S Baroni, et al.
Current Medicinal Chemistry|March 26, 2013
The relationship between epilepsy and depression: an updateM Catena-Dell'Osso, A Caserta, S Baroni, et al.
Current Medicinal Chemistry|November 30, 2010
Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?M Catena-Dell'Osso, C Bellantuono, G Consoli, et al.
Current Medicinal Chemistry|February 5, 2011
Is androstadienone a putative human pheromone?D Marazziti, P Torri, S Baroni, et al.
Current Medicinal Chemistry|November 5, 2011
Novel treatment options of binge eating disorderD Marazziti, L Rossi, S Baroni, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|March 14, 2008
The role of oxytocin in neuropsychiatric disordersD Marazziti, M Catena Dell'osso
Current Medicinal Chemistry|November 12, 2009
Second messenger modulation: a novel target of future antidepressants?D Marazziti, M Catena Dell'Osso, G Consoli, et al.
Current Medicinal Chemistry|August 18, 2010
Past, present and future drugs for the treatment of obsessive-compulsive disorderD Marazziti, G Consoli, S Baroni, et al.
European Review for Medical and Pharmacological Sciences|June 18, 2013
Adolescent depression: clinical features and therapeutic strategiesB Nardi, G Francesconi, M Catena-Dell'osso, et al.
Current Medicinal Chemistry|June 9, 2011
Serotonin receptors of type 6 (5-HT6): what can we expect from them?D Marazziti, S Baroni, M Catena Dell'Osso, et al.
European Review for Medical and Pharmacological Sciences|January 3, 2013
Latest advancements in the pharmacological treatment of binge eating disorderD Marazziti, M Corsi, S Baroni, et al.
Current Medicinal Chemistry|March 26, 2013
The relationship between epilepsy and depression: an updateM Catena-Dell'Osso, A Caserta, S Baroni, et al.
Current Medicinal Chemistry|November 30, 2010
Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?M Catena-Dell'Osso, C Bellantuono, G Consoli, et al.
Current Medicinal Chemistry|February 5, 2011
Is androstadienone a putative human pheromone?D Marazziti, P Torri, S Baroni, et al.
Current Medicinal Chemistry|November 5, 2011
Novel treatment options of binge eating disorderD Marazziti, L Rossi, S Baroni, et al.
Pageof 2